Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acute Gout Arthritis”

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT06169891
What this trial is testing

Recombinant Anti-IL-1β Humanized Monoclonal Antibody Injection in Chinese Participants With Acute Gout

Who this might be right for
Acute Gout
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 500
Large-scale testing (Phase 3)Ended earlyNCT01362608
What this trial is testing

Safety & Efficacy of Canakinumab (ACZ885) in Patients With Frequent Flares for Whom Nonsterodial Anti-Inflammatory Drug (NSAIDs) and/ or Colchicine Are Contraindicated, Not Tolerated or Ineffective

Who this might be right for
Gouty Arthritis
Novartis Pharmaceuticals 136
Testing effectiveness (Phase 2)UnknownNCT04462666
What this trial is testing

Oral Huzhang Granules for Acute Gouty Arthritis

Who this might be right for
Gouty Arthritis
Shanghai Yueyang Integrated Medicine Hospital 267
Not applicableUnknownNCT04069325
What this trial is testing

Efficacy and Safety of Simiaowan in Prevention of Acute Flares in Chronic Gout Patients Initiating Febuxostat Therapy

Who this might be right for
Gout Flare
Guang'anmen Hospital of China Academy of Chinese Medical Sciences 72
Testing effectiveness (Phase 2)Study completedNCT00798369
What this trial is testing

Targeted Dose Finding of Canakinumab (ACZ885) for Management of Acute Flare in Refractory or Contraindicated Gout Patients

Who this might be right for
Acute Gout
Novartis 200
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07498647
What this trial is testing

Clinical Trial of BR2251 Tablets for Patients With Primary Gout and Hyperuricemia

Who this might be right for
Gout and Hyperuricemia
BioRay Pharmaceutical Co., Ltd. 160
Large-scale testing (Phase 3)Study completedNCT05586958
What this trial is testing

Tigulixostat, Phase 3 Study, Placebo Controlled in Gout Patients

Who this might be right for
GoutHyperuricemiaGout Flare+1 more
LG Chem 354
Large-scale testing (Phase 3)Study completedNCT01029652
What this trial is testing

Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine Including a 12 Weeks Extension and an Open-label 48 Weeks Extension Study

Who this might be right for
Acute Gout
Novartis Pharmaceuticals 230
Testing effectiveness (Phase 2)Study completedNCT00663169
What this trial is testing

Efficacy and Safety of a Single Dose of Canakinumab (ACZ885) in Hospitalized Patients With Acute Gout

Who this might be right for
Arthritis, Gouty
Novartis 6
Not applicableWithdrawnNCT01775098
What this trial is testing

Allopurinol in Acute Gout

Who this might be right for
Gout
Université de Sherbrooke
Not applicableEnded earlyNCT03621215
What this trial is testing

The Effect of Tart Cherry Juice on Risk of Gout Attacks

Who this might be right for
Gout FlareGout Attack
Sheffield Hallam University 38
Testing effectiveness (Phase 2)Study completedNCT01712204
What this trial is testing

A Proof-of-Concept Study of AC-201 to Prevent Gout Flares

Who this might be right for
Gout Flares
TWi Biotechnology, Inc. 82
Large-scale testing (Phase 3)Study completedNCT05983445
What this trial is testing

Safety & Efffficacy of Genakumab in Patients With Frequent Flares

Who this might be right for
Acute Gout Arthritis
Changchun GeneScience Pharmaceutical Co., Ltd. 313
Not applicableUnknownNCT05744297
What this trial is testing

NLRP3 Inflammasome Activation Among Patients During Acute Gout Flares

Who this might be right for
Gout Arthritis
Centre Hospitalier Saint Joseph Saint Luc de Lyon 10
Testing effectiveness (Phase 2)WithdrawnNCT00997581
What this trial is testing

Apremilast Therapy for Acute Gouty Arthritis

Who this might be right for
Acute Gout
Dartmouth-Hitchcock Medical Center
Post-approval studies (Phase 4)Ended earlyNCT03636373
What this trial is testing

Pilot Study Evaluating The Efficacy Of Etanercept In Acute Gout

Who this might be right for
Gout Attack
Rutgers, The State University of New Jersey 5
Testing effectiveness (Phase 2)Ended earlyNCT04067492
What this trial is testing

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Evaluation of RPH-104 Administered at Different Doses to Patients With Acute Gout Attack

Who this might be right for
Gout Attack
R-Pharm 47
Testing effectiveness (Phase 2)Temporarily pausedNCT04844814
What this trial is testing

Anakinra vs Prednisone to Treat Gout Flare in Patients With Chronic Kidney Disease Stage 4/5 or Renal Transplantation

Who this might be right for
GoutChronic Kidney DiseaseRenal Transplantation
Assistance Publique - Hôpitaux de Paris 204
Not applicableNot Yet RecruitingNCT07625514
What this trial is testing

24-Week Recurrence Rate of Gout Following Firsekibart Treatment

Who this might be right for
Gout Flare
Second Affiliated Hospital, Zhejiang University, School of Medicine 264
Post-approval studies (Phase 4)Not Yet RecruitingNCT07661030
What this trial is testing

The Impact of Initiating Dotinurad Urate-Lowering Therapy at Different Time Windows on Gout Flare Resolution Time

Who this might be right for
Gout
First Affiliated Hospital of Wenzhou Medical University 142
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation